G protein-coupled receptor oligomerization and brain integration: Focus on adenosinergic transmission

Brain Research

Volumn 1476, Issue , 2012, Pages 86-95

  Ciruela, Francisco ^a   Fernández Dueñas, Víctor ^a   Llorente, Javier ^a   Borroto Escuela, Dasiel ^b   Cuffí, Maria L ^a   Carbonell, Lourdes ^a   Sánchez, Silvia ^a   Agnati, Luigi F ^c   Fuxe, Kjell ^b   Tasca, Carla I ^d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c IRCCS SAN CAMILLO HOSPITAL   (Italy)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

A2AR; Brain integration; D2R; mGlu5R; Oligomerization

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR; DOPAMINE; G PROTEIN COUPLED RECEPTOR; HETERODIMER; METABOTROPIC RECEPTOR; OLIGOMER; PROTEIN C FOS;

ADENOSINERGIC TRANSMISSION; BRAIN FUNCTION; CORPUS STRIATUM; GENETIC TRANSDUCTION; HUMAN; NERVE CELL; NEUROTRANSMISSION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ADENOSINE; ANIMALS; BRAIN; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84866908417     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.04.056     Document Type: Review

References (110)

1. M.P. Abbracchio, G. Burnstock, A. Verkhratsky, and H. Zimmermann Purinergic signalling in the nervous system: an overview Trends Neurosci. 32 2009 19 29
2. L.F. Agnati, K. Fuxe, I. Zini, P. Lenzi, and T. Hokfelt Aspects on receptor regulation and isoreceptor identification Med. Biol. 58 1980 182 187
3. L.F. Agnati, S. Ferré, C. Lluis, R. Franco, and K. Fuxe Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons Pharmacol. Rev. 55 2003 509 550
4. L. Albizu, M. Cottet, M. Kralikova, S. Stoev, R. Seyer, I. Brabet, T. Roux, H. Bazin, E. Bourrier, L. Lamarque, C. Breton, M.L. Rives, A. Newman, J. Javitch, E. Trinquet, M. Manning, J.P. Pin, B. Mouillac, and T. Durroux Time-resolved FRET between GPCR ligands reveals oligomers in native tissues Nat. Chem. Biol. 6 2010 587 594
5. A.F. Arnsten Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms Prog. Brain Res. 126 2000 183 192
6. S. Avissar, G. Amitai, and M. Sokolovsky Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states Proc. Natl. Acad. Sci. U. S. A. 80 1983 156 159
7. M. Bouvier, N. Heveker, R. Jockers, S. Marullo, and G. Milligan BRET analysis of GPCR oligomerization: newer does not mean better Nat. Methods 4 2007 3 4
8. N. Cabello, J. Gandia, D.C. Bertarelli, M. Watanabe, C. Lluis, R. Franco, S. Ferré, R. Lujan, and F. Ciruela Metabotropic glutamate type 5, dopamine D(2) and adenosine A(2a) receptors form higher-order oligomers in living cells J. Neurochem. 109 2009 1497 1507
9. P. Calabresi, R. Maj, N.B. Mercuri, and G. Bernardi Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum Neurosci. Lett. 142 1992 95 99
10. M. Canals, D. Marcellino, F. Fanelli, F. Ciruela, P. de Benedetti, S.R. Goldberg, K. Neve, K. Fuxe, L.F. Agnati, A.S. Woods, S. Ferré, C. Lluis, M. Bouvier, and R. Franco Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer J. Biol. Chem. 278 2003 46741 46749
11. Y. Cao, W.C. Sun, L. Jin, K.Q. Xie, and X.Z. Zhu Activation of adenosine A1 receptor modulates dopamine D1 receptor activity in stably cotransfected human embryonic kidney 293 cells Eur. J. Pharmacol. 548 2006 29 35
12. C. Capper-Loup, J.J. Canales, N. Kadaba, and A.M. Graybiel Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization J. Neurosci. 22 2002 6218 6227
13. F. Ciruela, V. Casado, J. Mallol, E.I. Canela, C. Lluis, and R. Franco Immunological identification of A1 adenosine receptors in brain cortex J. Neurosci. Res. 42 1995 818 828
14. F. Ciruela, M. Escriche, J. Burgueno, E. Angulo, V. Casado, M.M. Soloviev, E.I. Canela, J. Mallol, W.Y. Chan, C. Lluis, R.A. McIlhinney, and R. Franco Metabotropic glutamate 1alpha and adenosine A1 receptors assemble into functionally interacting complexes J. Biol. Chem. 276 2001 18345 18351
15. F. Ciruela, L. Canela, J. Burgueno, A. Soriguera, N. Cabello, E.I. Canela, V. Casado, A. Cortes, J. Mallol, A.S. Woods, S. Ferré, C. Lluis, and R. Franco Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins: focus on adenosine, dopamine, and metabotropic glutamate receptor function J. Mol. Neurosci. 26 2005 277 292
16. F. Ciruela, V. Casado, R.J. Rodrigues, R. Lujan, J. Burgueno, M. Canals, J. Borycz, N. Rebola, S.R. Goldberg, J. Mallol, A. Cortes, E.I. Canela, J.F. Lopez-Gimenez, G. Milligan, C. Lluis, R.A. Cunha, S. Ferré, and R. Franco Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers J. Neurosci. 26 2006 2080 2087
17. F. Ciruela, S. Ferré, V. Casado, A. Cortes, R.A. Cunha, C. Lluis, and R. Franco Heterodimeric adenosine receptors: a device to regulate neurotransmitter release Cell. Mol. Life Sci. 63 2006 2427 2431
18. F. Ciruela, J.P. Vilardaga, and V. Fernandez-Duenas Lighting up multiprotein complexes: lessons from GPCR oligomerization Trends Biotechnol. 28 2010 407 415
19. F. Ciruela, M. Gomez-Soler, D. Guidolin, D.O. Borroto-Escuela, L.F. Agnati, K. Fuxe, and V. Fernandez-Duenas Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain Biochim. Biophys. Acta 1808 2011 1245 1255
20. R. Coccurello, N. Breysse, and M. Amalric Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing parkinsonian deficits in rats Neuropsychopharmacology 29 2004 1451 1461
21. S. Cristovao-Ferreira, G. Navarro, M. Brugarolas, K. Perez-Capote, S.H. Vaz, G. Fattorini, F. Conti, C. Lluis, J.A. Ribeiro, P.J. McCormick, V. Casado, R. Franco, and A.M. Sebastiao Modulation of GABA transport by adenosine A1R-A2AR heteromers, which are coupled to both gs- and G(i/o)-proteins J. Neurosci. 31 2011 15629 15639
22. P. d'Alcantara, C. Ledent, S. Swillens, and S.N. Schiffmann Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission Neuroscience 107 2001 455 464
23. J.K. Dreher, and D.M. Jackson Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats Brain Res. 487 1989 267 277
24. T.V. Dunwiddie The physiological role of adenosine in the central nervous system Int. Rev. Neurobiol. 27 1985 63 139
25. T.V. Dunwiddie, and S.A. Masino The role and regulation of adenosine in the central nervous system Annu. Rev. Neurosci. 24 2001 31 55
26. S. Ferré, and K. Fuxe Adenosine as a volume transmission signal. A feedback detector of neuronal activation Prog. Brain Res. 125 2000 353 361
27. S. Ferré, W.T. O'Connor, K. Fuxe, and U. Ungerstedt The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain J. Neurosci. 13 1993 5402 5406
28. S. Ferré, P. Popoli, L. Gimenez-Llort, U.B. Finnman, E. Martinez, A. Scotti de Carolis, and K. Fuxe Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors Neuroreport 6 1994 73 76
29. S. Ferré, B.B. Fredholm, M. Morelli, P. Popoli, and K. Fuxe Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia Trends Neurosci. 20 1997 482 487
30. S. Ferré, M. Torvinen, K. Antoniou, E. Irenius, O. Civelli, E. Arenas, B.B. Fredholm, and K. Fuxe Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells J. Biol. Chem. 273 1998 4718 4724
31. S. Ferré, M. Karcz-Kubicha, B.T. Hope, P. Popoli, J. Burgueno, M.A. Gutierrez, V. Casado, K. Fuxe, S.R. Goldberg, C. Lluis, R. Franco, and F. Ciruela Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function Proc. Natl. Acad. Sci. U. S. A. 99 2002 11940 11945
32. S. Ferré, F. Ciruela, M. Canals, D. Marcellino, J. Burgueno, V. Casado, J. Hillion, M. Torvinen, F. Fanelli, P. Benedetti Pd, S.R. Goldberg, M. Bouvier, K. Fuxe, L.F. Agnati, C. Lluis, R. Franco, and A. Woods Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders Parkinsonism Relat. Disord. 10 2004 265 271
33. S. Ferré, L.F. Agnati, F. Ciruela, C. Lluis, A.S. Woods, K. Fuxe, and R. Franco Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module Brain Res. Rev. 55 2007 55 67
34. S. Ferré, F. Ciruela, C. Quiroz, R. Lujan, P. Popoli, R.A. Cunha, L.F. Agnati, K. Fuxe, A.S. Woods, C. Lluis, and R. Franco Adenosine receptor heteromers and their integrative role in striatal function Sci. World J. 7 2007 74 85
35. S. Ferré, R. Baler, M. Bouvier, M.G. Caron, L.A. Devi, T. Durroux, K. Fuxe, S.R. George, J.A. Javitch, M.J. Lohse, K. Mackie, G. Milligan, K.D. Pfleger, J.P. Pin, N.D. Volkow, M. Waldhoer, A.S. Woods, and R. Franco Building a new conceptual framework for receptor heteromers Nat. Chem. Biol. 5 2009 131 134
36. R. Franco, C. Lluis, E.I. Canela, J. Mallol, L. Agnati, V. Casado, F. Ciruela, S. Ferré, and K. Fuxe Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins J. Neural Transm. 114 2007 93 104
37. C.M. Fraser, and J.C. Venter The size of the mammalian lung beta 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography Biochem. Biophys. Res. Commun. 109 1982 21 29
38. B.B. Fredholm Purinoceptors in the nervous system Pharmacol. Toxicol. 76 1995 228 239
39. B.B. Fredholm, M.P. Abbracchio, G. Burnstock, J.W. Daly, T.K. Harden, K.A. Jacobson, P. Leff, and M. Williams Nomenclature and classification of purinoceptors Pharmacol. Rev. 46 1994 143 156
40. B.B. Fredholm, K. Battig, J. Holmen, A. Nehlig, and E.E. Zvartau Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol. Rev. 51 1999 83 133
41. B.B. Fredholm, E. Irenius, B. Kull, and G. Schulte Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells Biochem. Pharmacol. 61 2001 443 448
42. B.B. Fredholm, J.F. Chen, R.A. Cunha, P. Svenningsson, and J.M. Vaugeois Adenosine and brain function Int. Rev. Neurobiol. 63 2005 191 270
43. K. Fuxe, S. Ferré, M. Zoli, and L.F. Agnati Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia Brain Res. Brain Res. Rev. 26 1998 258 273
44. K. Fuxe, L.F. Agnati, K. Jacobsen, J. Hillion, M. Canals, M. Torvinen, B. Tinner-Staines, W. Staines, D. Rosin, A. Terasmaa, P. Popoli, G. Leo, V. Vergoni, C. Lluis, F. Ciruela, R. Franco, and S. Ferré Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease Neurology 61 2003 S19 S23
45. K. Fuxe, D. Marcellino, D.O. Borroto-Escuela, M. Guescini, V. Fernandez-Duenas, S. Tanganelli, A. Rivera, F. Ciruela, and L.F. Agnati Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders CNS Neurosci. Ther. 16 2010 e18 e42
46. S.R. George, S.P. Lee, G. Varghese, P.R. Zeman, P. Seeman, G.Y. Ng, and B.F. O'Dowd A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization J. Biol. Chem. 273 1998 30244 30248
47. C.R. Gerfen Basal ganglia G. Paxinos, The Rat Nervous System 2004 Elsevier Academic Press Amsterdam 445 508
48. C.R. Gerfen, and C.J. Wilson The basal ganglia L.W. Swanson, A. Björklund, T. Hökfelt, Handbook of Chemical Neuroanatomy vol. 12 1996 Elsevier Amsterdam 371 468
49. C.R. Gerfen, T.M. Engber, L.C. Mahan, Z. Susel, T.N. Chase, F.J. Monsma Jr., and D.R. Sibley D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons Science 250 1990 1429 1432
50. C.R. Gerfen, K.A. Keefe, and E.B. Gauda D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons J. Neurosci. 15 1995 8167 8176
51. S. Gines, J. Hillion, M. Torvinen, S. Le Crom, V. Casado, E.I. Canela, S. Rondin, J.Y. Lew, S. Watson, M. Zoli, L.F. Agnati, P. Verniera, C. Lluis, S. Ferré, K. Fuxe, and R. Franco Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes Proc. Natl. Acad. Sci. U. S. A. 97 2000 8606 8611
52. P.S. Goldman-Rakic The cortical dopamine system: role in memory and cognition Adv. Pharmacol. 42 1998 707 711
53. P. Gubellini, E. Saulle, D. Centonze, C. Costa, D. Tropepi, G. Bernardi, F. Conquet, and P. Calabresi Corticostriatal LTP requires combined mGluR1 and mGluR5 activation Neuropharmacology 44 2003 8 16
54. J.T. Herberg, J. Codina, K.A. Rich, F.J. Rojas, and R. Iyengar The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor J. Biol. Chem. 259 1984 9285 9294
55. B.D. Hettinger, A. Lee, J. Linden, and D.L. Rosin Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum J. Comp. Neurol. 431 2001 331 346
56. M. Hollmann, and S. Heinemann Cloned glutamate receptors Annu. Rev. Neurosci. 17 1994 31 108
57. K.A. Jacobson, and Z.G. Gao Adenosine receptors as therapeutic targets Nat. Rev. Drug Discov. 5 2006 247 264
58. J.R. James, M.I. Oliveira, A.M. Carmo, A. Iaboni, and S.J. Davis A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer Nat. Methods 3 2006 1001 1006
59. A. Kachroo, L.R. Orlando, D.K. Grandy, J.F. Chen, A.B. Young, and M.A. Schwarzschild Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and Parkinsonian mice J. Neurosci. 25 2005 10414 10419
60. K.A. Keefe, and C.R. Gerfen D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression Neuroscience 66 1995 903 913
61. M. Kimura, N. Saitoh, and T. Takahashi Adenosine A(1) receptor-mediated presynaptic inhibition at the calyx of held of immature rats J. Physiol. 553 2003 415 426
62. S. Latini, and F. Pedata Adenosine in the central nervous system: release mechanisms and extracellular concentrations J. Neurochem. 79 2001 463 484
63. S. Le Crom, D. Prou, and P. Vernier Autocrine activation of adenosine A1 receptors blocks D1A but not D1B dopamine receptor desensitization J. Neurochem. 82 2002 1549 1552
64. S.P. Lee, C.H. So, A.J. Rashid, G. Varghese, R. Cheng, A.J. Lanca, B.F. O'Dowd, and S.R. George Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal J. Biol. Chem. 279 2004 35671 35678
65. R.J. Lefkowitz The superfamily of heptahelical receptors Nat. Cell Biol. 2 2000 E133 E136
66. M. Lindskog, P. Svenningsson, B.B. Fredholm, P. Greengard, and G. Fisone Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms Neuroscience 88 1999 1005 1008
67. O. Lindvall, and A. Bjorklund Anatomy of the dopaminergic neuron systems in the rat brain Adv. Biochem. Psychopharmacol. 19 1978 1 23
68. A. Maggi, D.C. U'Prichard, and S.J. Enna Beta-adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system Science 207 1980 645 647
69. R.B. Marala, and S.J. Mustafa Direct evidence for the coupling of A2-adenosine receptor to stimulatory guanine nucleotide-binding-protein in bovine brain striatum J. Pharmacol. Exp. Ther. 266 1993 294 300
70. P.H. McDonald, and R.J. Lefkowitz Beta-arrestins: new roles in regulating heptahelical receptors' functions Cell. Signal. 13 2001 683 689
71. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Dopamine receptors: from structure to function Physiol. Rev. 78 1998 189 225
72. K.A. Moore, R.A. Nicoll, and D. Schmitz Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses Proc. Natl. Acad. Sci. U. S. A. 100 2003 14397 14402
73. A. Nehlig Are we dependent upon coffee and caffeine? A review on human and animal data Neurosci. Biobehav. Rev. 23 1999 563 576
74. G.Y. Ng, S.R. George, R.L. Zastawny, M. Caron, M. Bouvier, M. Dennis, and B.F. O'Dowd Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition Biochemistry 32 1993 11727 11733
75. G.Y. Ng, B. Mouillac, S.R. George, M. Caron, M. Dennis, M. Bouvier, and B.F. O'Dowd Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor Eur. J. Pharmacol. 267 1994 7 19
76. G.Y. Ng, B.F. O'Dowd, M. Caron, M. Dennis, M.R. Brann, and S.R. George Phosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cells J. Neurochem. 63 1994 1589 1595
77. G.Y. Ng, B.F. O'Dowd, S.P. Lee, H.T. Chung, M.R. Brann, P. Seeman, and S.R. George Dopamine D2 receptor dimers and receptor-blocking peptides Biochem. Biophys. Res. Commun. 227 1996 200 204
78. A. Nishi, F. Liu, S. Matsuyama, M. Hamada, H. Higashi, A.C. Nairn, and P. Greengard Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling Proc. Natl. Acad. Sci. U. S. A. 100 2003 1322 1327
79. M.E. Olah, and G.L. Stiles Adenosine receptor subtypes: characterization and therapeutic regulation Annu. Rev. Pharmacol. Toxicol. 35 1995 581 606
80. J.W. Olney, and L.G. Sharpe Brain lesions in an infant rhesus monkey treated with monsodium glutamate Science 166 1969 386 388
81. K. Ossowska, J. Konieczny, S. Wolfarth, J. Wieronska, and A. Pilc Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats Neuropharmacology 41 2001 413 420
82. T.M. Palmer, and G.L. Stiles Adenosine receptors Neuropharmacology 34 1995 683 694
83. 3 receptor signaling in the central nervous system P.A. Borea, A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics vol. 1 2010 Springer Science+Business Media B.V Amsterdam 165 188
84. M.L. Perreault, A. Hasbi, M. Alijaniaram, T. Fan, G. Varghese, P.J. Fletcher, P. Seeman, B.F. O'Dowd, and S.R. George The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: Increased high affinity state following amphetamine and in schizophrenia J. Biol. Chem. 285 2010 36625 36634
85. G.L. Peterson, L.C. Rosenbaum, D.J. Broderick, and M.I. Schimerlik Physical properties of the purified cardiac muscarinic acetylcholine receptor Biochemistry 25 1986 3189 3202
86. J.P. Pin, and R. Duvoisin The metabotropic glutamate receptors: structure and functions Neuropharmacology 34 1995 1 26
87. P. Popoli, A. Pezzola, M. Torvinen, R. Reggio, A. Pintor, L. Scarchilli, K. Fuxe, and S. Ferré The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors Neuropsychopharmacology 25 2001 505 513
88. A.J. Rashid, C.H. So, M.M. Kong, T. Furtak, M. El-Ghundi, R. Cheng, B.F. O'Dowd, and S.R. George D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum Proc. Natl. Acad. Sci. U. S. A. 104 2007 654 659
89. R. Rimondini, S. Ferré, S.O. Ogren, and K. Fuxe Adenosine A2A agonists: a potential new type of atypical antipsychotic Neuropsychopharmacology 17 1997 82 91
90. R. Rimondini, S. Ferré, L. Gimenez-Llort, S.O. Ogren, and K. Fuxe Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats Eur. J. Pharmacol. 347 1998 153 158
91. S. Ryzhov, A.E. Goldstein, I. Biaggioni, and I. Feoktistov Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells Mol. Pharmacol. 70 2006 727 735
92. C.A. Salvatore, M.A. Jacobson, H.E. Taylor, J. Linden, and R.G. Johnson Molecular cloning and characterization of the human A3 adenosine receptor Proc. Natl. Acad. Sci. U. S. A. 90 1993 10365 10369
93. S.N. Schiffmann, G. Fisone, R. Moresco, R.A. Cunha, and S. Ferré Adenosine A2A receptors and basal ganglia physiology Prog. Neurobiol. 83 2007 277 292
94. W. Schultz Getting formal with dopamine and reward Neuron 36 2002 241 263
95. A.M. Sebastiao, and J.A. Ribeiro Fine-tuning neuromodulation by adenosine Trends Pharmacol. Sci. 21 2000 341 346
96. T. Shindou, H. Nonaka, P.J. Richardson, A. Mori, H. Kase, and M. Ichimura Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidus Br. J. Pharmacol. 136 2002 296 302
97. Y. Smith, A. Charara, J.E. Hanson, M. Paquet, and A.I. Levey GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates J. Anat. 196 Pt 4 2000 555 576
98. S.H. Snyder Adenosine as a neuromodulator Annu. Rev. Neurosci. 8 1985 103 124
99. P. Svenningsson, M. Lindskog, C. Ledent, M. Parmentier, P. Greengard, B.B. Fredholm, and G. Fisone Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors Proc. Natl. Acad. Sci. U. S. A. 97 2000 1856 1860
100. J.D. Sweatt The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory J. Neurochem. 76 2001 1 10
101. N.R. Swerdlow, and G.F. Koob Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-striato-palido-thalamic function Behav. Brain Sci. 10 1987 197 245
102. Tebano, M.T., Martire, A., Popoli, P., in press. Adenosine A(2A)-Cannabinoid CB(1) receptor interaction: an integrative mechanism in striatal glutamatergic neurotransmission. Brain Res.
103. S. Toda, L.F. Alguacil, and P.W. Kalivas Repeated cocaine administration changes the function and subcellular distribution of adenosine A1 receptor in the rat nucleus accumbens J. Neurochem. 87 2003 1478 1484
104. A. Tozzi, A. Tscherter, V. Belcastro, M. Tantucci, C. Costa, B. Picconi, D. Centonze, P. Calabresi, and F. Borsini Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission Neuropharmacology 53 2007 783 789
105. A. Vallano, V. Fernandez-Duenas, C. Pedros, J.M. Arnau, and F. Ciruela An update on adenosine A2A receptors as drug target in parkinson's disease CNS Neurol. Disord. Drug Targets 10 2011 659 669
106. N.D. Volkow, J.S. Fowler, G.J. Wang, and R.Z. Goldstein Role of dopamine, the frontal cortex and memory circuits in drug addiction: Insight from imaging studies Neurobiol. Learn. Mem. 78 2002 610 624
107. L.G. Wu, and P. Saggau Presynaptic inhibition of elicited neurotransmitter release Trends Neurosci. 20 1997 204 212
108. H. Yawo, and N. Chuhma Preferential inhibition of omega-conotoxin- sensitive presynaptic Ca2+ channels by adenosine autoreceptors Nature 365 1993 256 258
109. J. Yelnik Functional anatomy of the basal ganglia Mov. Disord. 17 Suppl. 3 2002 S15 S21
110. P. Zawarynski, T. Tallerico, P. Seeman, S.P. Lee, B.F. O'Dowd, and S.R. George Dopamine D2 receptor dimers in human and rat brain FEBS Lett. 441 1998 383 386